IL161521A0 - N-formyl derivatives of paroxetine - Google Patents

N-formyl derivatives of paroxetine

Info

Publication number
IL161521A0
IL161521A0 IL16152102A IL16152102A IL161521A0 IL 161521 A0 IL161521 A0 IL 161521A0 IL 16152102 A IL16152102 A IL 16152102A IL 16152102 A IL16152102 A IL 16152102A IL 161521 A0 IL161521 A0 IL 161521A0
Authority
IL
Israel
Prior art keywords
paroxetine
formyl derivatives
formyl
derivatives
Prior art date
Application number
IL16152102A
Other languages
English (en)
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of IL161521A0 publication Critical patent/IL161521A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16152102A 2001-10-22 2002-10-15 N-formyl derivatives of paroxetine IL161521A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33043001P 2001-10-22 2001-10-22
PCT/NL2002/000654 WO2003044012A1 (en) 2001-10-22 2002-10-15 N-formyl derivatives of paroxetine

Publications (1)

Publication Number Publication Date
IL161521A0 true IL161521A0 (en) 2004-09-27

Family

ID=23289741

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16152102A IL161521A0 (en) 2001-10-22 2002-10-15 N-formyl derivatives of paroxetine

Country Status (15)

Country Link
US (3) US6703408B2 (pt)
EP (1) EP1440067B1 (pt)
AR (1) AR036860A1 (pt)
AT (1) ATE285408T1 (pt)
AU (1) AU2002330771A1 (pt)
CA (1) CA2464327A1 (pt)
DE (2) DE60202381T2 (pt)
DK (1) DK1440067T3 (pt)
ES (1) ES2230516T3 (pt)
HU (1) HUP0401895A2 (pt)
IL (1) IL161521A0 (pt)
NO (1) NO20042101L (pt)
NZ (1) NZ532432A (pt)
PT (1) PT1440067E (pt)
WO (1) WO2003044012A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
EP1778183B1 (en) * 2004-08-18 2018-06-27 Synthon B.V. Liquid paroxetine compositions
US20070112031A1 (en) * 2005-11-14 2007-05-17 Gant Thomas G Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CN109507349A (zh) * 2017-09-15 2019-03-22 万全万特制药江苏有限公司 液相色谱法分离测定帕罗西汀中间体光学异构体的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
EP0812829A1 (en) 1996-06-14 1997-12-17 Ontogen Corporation Substituted imidazoles as modulators of multi-drug resistance
IL133140A0 (en) 1997-05-29 2001-03-19 Smithkline Beecham Corp Novel process for the preparation of 4-aryl-piperidines
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
CZ20011465A3 (cs) 1998-11-02 2001-08-15 Synthon B. V. Způsob přípravy 4-arylpiperidin-3-methanolů a příbuzných sloučenin
US6239126B1 (en) * 1998-12-17 2001-05-29 American Home Products Corporation Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
GB9916392D0 (en) 1999-07-13 1999-09-15 Smithkline Beecham Plc Novel process
IT1313702B1 (it) 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
AU2001296084A1 (en) * 2000-08-28 2002-03-13 Synthon B.V. Paroxetine compositions and processes for making the same
US6755653B2 (en) * 2001-10-25 2004-06-29 Cubic Defense Systems, Inc. System and method for preventing cheating in a simulated combat exercise

Also Published As

Publication number Publication date
ES2230516T3 (es) 2005-05-01
EP1440067B1 (en) 2004-12-22
PT1440067E (pt) 2005-02-28
CA2464327A1 (en) 2003-05-30
US20040147497A1 (en) 2004-07-29
WO2003044012A1 (en) 2003-05-30
AR036860A1 (es) 2004-10-06
US6703408B2 (en) 2004-03-09
EP1440067A1 (en) 2004-07-28
NO20042101L (no) 2004-05-21
DE60202381T2 (de) 2005-12-08
ATE285408T1 (de) 2005-01-15
DE60202381D1 (de) 2005-01-27
DE20220955U1 (de) 2004-09-02
US20030125560A1 (en) 2003-07-03
HUP0401895A2 (hu) 2004-12-28
AU2002330771A1 (en) 2003-06-10
NZ532432A (en) 2005-02-25
DK1440067T3 (da) 2005-04-11
US20040266825A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
IL156737A0 (en) Substituted amine derivatives and methods of use
AU154703S (en) Set of trocars
AU2001263021A1 (en) Alkylamine derivatives of dihydropyridine npy antagonists
PL377861A1 (pl) Podstawione pochodne aminowe oraz sposoby wykorzystania
GB0219896D0 (en) Dihydropyridine derivatives
ZA200309522B (en) Substituted cyclohexane-1-4diamine derivatives
EP1386930A4 (en) EXENDINDERIVATE
EP1539692A4 (en) FURANO DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
EP1549646A4 (en) DERIVATIVES OF PIPERIDINE
IL156595A0 (en) Therapeutic heterocyclic compounds
IL162765A0 (en) Piperidine derivatives
IL157889A0 (en) Substituted benzofuran-2-carboxamide derivatives
AU2002305162A1 (en) Polymorphs of fexofenadine hydrochloride
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
IL148825A0 (en) Derivatives of isoflavones
IL161521A0 (en) N-formyl derivatives of paroxetine
AU2003298725A8 (en) Preparation of metallotexaphyrins
HK1073243A1 (en) Use of N-(indolecarbonyl-) piperazine derivatives
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
GB2387171B (en) Synthesis of enamines
GB0104583D0 (en) Piperidine derivatives
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
AU2002237189A1 (en) New use of phencynonate hydrochloride
AU2002238356A1 (en) New use of phencynonate hydrochloride